Peter Daggett

After a few months of reflection on my gymnastics career, I thought it was time that I share it with the world. This is my story. I hope that you're able to take something from it that gives you serenity in your struggles. @peter.daggett/99-1-serenity-in-the-struggle-37eff3936eb2" target="_blank" rel="nofollow noopener">medium.com/@peter.daggett…

This launch coincides with our biggest milestone yet: Medfinder has helped over 30,000 patients access the medications they need. That community is what made this dataset possible. The tracker is how we give the insight back.

The tracker is free and public: medfinder.com/shortage-track… Built for patients, journalists, clinicians, and policymakers working on medication access - but the full dataset goes much deeper.

The FDA officially lists 72 medications as being in shortage. In the last 30 days, patients searched MedFinder for 1,233 unique medications they couldn't find at the pharmacy. A 17x gap between what's reported and what patients actually experience. 🧵

We're bringing on our first full time marketing & growth hire at @trymedfinder We need a killer generalist executor to join our team to help us take growth on our DTC platform to the next level. I don't care if you have 5 years of experience or just some internships. If you are intelligent, exceptional, learn very quickly, and are excited about working extremely hard, I'd love to chat with you app.withrapha.com/job/1586?r=259…

@laurenlself We built it @trymedfinder

Hello Sharks. Today I’m seeking $14mm for 2% equity to build an AI agent that will call every pharmacy in a 10 mile radius to see if they have been affected by The Adderall Shortage™️

Here’s a summary of today’s discussion on advisory shares from the WhatsApp group: 1) Skepticism Toward Advisory Shares @adhoc97: He mentioned that giving someone shares doesn't necessarily increase their incentive enough long term—they might stay engaged for two weeks, then stop being helpful​. 2) Preferred Alternative: Get Advisors to Invest Instead @MasoudByDesign: If an advisor really wants to help, they should be willing to invest money in the company. Advice is abundant and free, so equity should go to those providing true strategic value​. @M___Morgenstern: Advice is free these days. Get them to angel. (i.e., push advisors to invest instead of just taking equity)​. 3) Vesting and Cliff Structures @PeterDaggett : A one-year cliff is the best way to structure advisory shares since most advisors overpromise and underdeliver​. @aaronShaki & others: Some advisors may push for a six-month cliff, but the group consensus was that one year is better for weeding out ineffective advisors​. VC & Founder: A milestone-based cliff (instead of just time-based) might be more functional, but some lawyers advise against it because it’s harder to enforce legally​. 4) Performance-Based Equity Allocation @theSpencerFoust: He only accepted advisory shares after proving value (i.e., helping close customers first). If an advisor isn't excited enough to help before getting shares, giving them equity just creates messy expectations​. 5) Founder Institute’s FAST Agreement VC: Recommended using the Founder Institute’s FAST Agreement, which functions like a SAFE for advisors and includes standard equity allocations based on involvement and company stage. The majority agreed that advisory shares should be given very selectively. The best advisors either invest in the company or prove their value first before getting equity.

@longtimeonleft @insitohealth Thank you so much!! This means a lot to us

@PeterDaggett @insitohealth Congratulations Mr. Daggett! Your customer service team treats me w/empathy, kindness & dignity, these qualities are often in short supply in the medical system. I am so grateful to Medfinder for improving the quality of my life. Here’s to 20k more pts!

I'm in shock. This past week, while checking on our metrics, we noticed something incredible. We've officially crossed the 10,000 patient mark at @insitohealth It feels completely surreal to us that so many people across the US have trusted us with helping them get access to their medications, and there are countless people to thank for this massive milestone. We don't spend a lot of time looking back on the past, but it feels incredible to be able to look back at all the people we've been able to help over the last 12 months. We are so grateful for each and every one of you. To all of you that have helped us get to this milestone - THANK YOU! We couldn't have done it without you, and we're so excited to continue along with each of you on this journey. We still have a long way to go, but this one feels like a moment to celebrate. Cheers to the next 10,000!

Medfinder works! I bought a package with them at a very affordable price and can attest to the effectiveness of their service plus I guarantee they will treat you w/dignity, respect & kindness.

I'm hiring cracked engineers in Boston @insitohealth If you want to work insanely hard on something that actually matters - my DMs are open

Shout out to the team at @insitohealth for helping patients who are struggling to find medications due to the drug shortages plaguing our nation. They do the work and text you the pharmacy info. Got mine in 24 hours. If they can’t locate it you don’t pay. medfinder.com

@tjparker 100% agree, this is going to be a big help for us in unlocking pharmacy data

I’ve fully come around to the thesis that automated AI phone calls are going to accelerate / force the adoption of actual API’s in healthcare. Which is great.

Huge milestone this week - we've helped over 5,000 patients find their hard to find medications. Crazy to look back to January when we helped our very first patient find their meds.

Big milestone today - just crossed 100 five star reviews for medfinder.com Feels incredible to get that kind of support from our customers. Build something people want.

@DrNadolsky Here to help! Check out medfinder.com - we've helped thousands of patients locate their GLP-1s at pharmacies near them.

The GLP-1 shortages are so bad that I have patients driving 3-4 hours to pharmacies that have Zepbound etc in stock.

@melina_manolas Definitely an interesting approach! Check out medfinder.com - thousands of people have used us to locate their GLP-1s!

We have been struggling to know which pharmacies carry or don’t carry, or are on shortage, for certain GLP-1 and GLP-1/GIP agonists. This supply tracker tool is an interesting way to do this for us